Skip to main content
Erschienen in: Digestive Diseases and Sciences 3/2013

01.03.2013 | Original Article

Physicians’ Opinions of Stress Ulcer Prophylaxis: Survey Results from a Large Urban Medical Center

verfasst von: Charles P. Koczka, Laura B. Geraldino-Pardilla, Adam J. Goodman

Erschienen in: Digestive Diseases and Sciences | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

Stress ulcer prophylaxis (SUP) has been increasingly prescribed for patients admitted to medical wards. The knowledge, attitudes, and practices of those in the healthcare profession regarding use of SUP in medical wards are understudied.

Methods

A survey consisting of closed-ended questions and multiple-choice queries was handed out during grand rounds.

Results

One hundred people (39 attending physicians, 61 residents) completed the survey. More attending physicians (41 vs. 30 %) believed SUP was indicated for patients treated in a non-intensive-care medical ward (P = 0.2357). All residents preferred a proton-pump inhibitor (PPI) for SUP compared with 85 % of attending physicians (P < 0.05). Despite equal agreement that PPIs were not harmless, more attending physicians than residents agreed that using PPIs increased the risk of community-acquired pneumonia (P < 0.05). More residents than attending physicians agreed on the use of SUP for patients suffering from major burns and for those with liver failure. In situations of respiratory distress not requiring intubation and in cases of steroid treatment for a chronic obstructive pulmonary disease flare, more attending physicians than residents felt SUP was required. Approaching a statistically significant difference, more attending physicians than residents felt that being too busy to question SUP indication and the perception of PPIs as harmless affected decision making.

Conclusion

Despite the publication of guidelines, misuse of gastric acid suppressants continues to occur, even by attending physicians. More complete understanding of the need and occasion for SUP use should result in more cautious use.
Literatur
1.
Zurück zum Zitat Naunton M, Peterson GM, Bleasel MD. Overuse of proton-pump inhibitors. J Clin Pharm Ther. 2000;25:333–340.PubMedCrossRef Naunton M, Peterson GM, Bleasel MD. Overuse of proton-pump inhibitors. J Clin Pharm Ther. 2000;25:333–340.PubMedCrossRef
2.
Zurück zum Zitat Leditschke IA, Coombes JA. Concordance between use of proton-pump inhibitors and prescribing guidelines. Med J Aust. 2000;172:564.PubMed Leditschke IA, Coombes JA. Concordance between use of proton-pump inhibitors and prescribing guidelines. Med J Aust. 2000;172:564.PubMed
3.
Zurück zum Zitat Parente F, Cucino C, Gallus S, et al. Hospital use of acid-suppressive medications and its fall-out on prescribing in general practice: a 1-month survey. Aliment Pharmacol Ther. 2003;17:1503–1506.PubMedCrossRef Parente F, Cucino C, Gallus S, et al. Hospital use of acid-suppressive medications and its fall-out on prescribing in general practice: a 1-month survey. Aliment Pharmacol Ther. 2003;17:1503–1506.PubMedCrossRef
4.
Zurück zum Zitat Walker NM, McDonald J. An evaluation of the use of proton-pump inhibitors. Pharm World Sci. 2001;23:116–117.PubMedCrossRef Walker NM, McDonald J. An evaluation of the use of proton-pump inhibitors. Pharm World Sci. 2001;23:116–117.PubMedCrossRef
5.
Zurück zum Zitat Sebastian SS, Kernan N, Qasim A, O’Morain CA, Buckley M. Appropriateness of gastric antisecretory therapy in hospital practice. Ir J Med Sci. 2003;172:115–117.PubMedCrossRef Sebastian SS, Kernan N, Qasim A, O’Morain CA, Buckley M. Appropriateness of gastric antisecretory therapy in hospital practice. Ir J Med Sci. 2003;172:115–117.PubMedCrossRef
6.
Zurück zum Zitat Grant K, Al-Adhami N, Tordoff J, Livesey J, Barbezat G, Reith D. Continuation of proton-pump inhibitors from hospital to community. Pharm World Sci. 2006;28:189–193.PubMedCrossRef Grant K, Al-Adhami N, Tordoff J, Livesey J, Barbezat G, Reith D. Continuation of proton-pump inhibitors from hospital to community. Pharm World Sci. 2006;28:189–193.PubMedCrossRef
7.
Zurück zum Zitat Pham CQ, Regal RE, Bostwick TR, Knauf KS. Acid suppressive therapy use on an inpatient internal medicine service. Ann Pharmacother. 2006;40:1261–1266.PubMedCrossRef Pham CQ, Regal RE, Bostwick TR, Knauf KS. Acid suppressive therapy use on an inpatient internal medicine service. Ann Pharmacother. 2006;40:1261–1266.PubMedCrossRef
8.
Zurück zum Zitat Kleiman RL, Adair CG, Ephgrave KS. Stress ulcers: current understanding of pathogenesis and prophylaxis. Drug Intell Clin Pharm. 1988;22:452–460.PubMed Kleiman RL, Adair CG, Ephgrave KS. Stress ulcers: current understanding of pathogenesis and prophylaxis. Drug Intell Clin Pharm. 1988;22:452–460.PubMed
9.
Zurück zum Zitat Grube RR, May DB. Stress ulcer prophylaxis in hospitalized patients not in intensive care units. Am J Health Syst Pharm. 2007;64:1396–1400.PubMedCrossRef Grube RR, May DB. Stress ulcer prophylaxis in hospitalized patients not in intensive care units. Am J Health Syst Pharm. 2007;64:1396–1400.PubMedCrossRef
10.
Zurück zum Zitat ASHP Therapeutic Guidelines on Stress Ulcer Prophylaxis. ASHP Commission on Therapeutics and approved by the ASHP Board of Directors on November 14, 1998. Am J Health Syst Pharm. 1999;56:347–379. ASHP Therapeutic Guidelines on Stress Ulcer Prophylaxis. ASHP Commission on Therapeutics and approved by the ASHP Board of Directors on November 14, 1998. Am J Health Syst Pharm. 1999;56:347–379.
11.
Zurück zum Zitat Murphy CE, Stevens AM, Ferrentino N, et al. Frequency of inappropriate continuation of acid suppressive therapy after discharge in patients who began therapy in the surgical intensive care unit. Pharmacotherapy. 2008;28:968–976.PubMedCrossRef Murphy CE, Stevens AM, Ferrentino N, et al. Frequency of inappropriate continuation of acid suppressive therapy after discharge in patients who began therapy in the surgical intensive care unit. Pharmacotherapy. 2008;28:968–976.PubMedCrossRef
12.
Zurück zum Zitat Saccar CL. The pharmacology of esomeprazole and its role in gastric acid related diseases. Expert Opin Drug Metab Toxicol. 2009;5:1113–1124.PubMedCrossRef Saccar CL. The pharmacology of esomeprazole and its role in gastric acid related diseases. Expert Opin Drug Metab Toxicol. 2009;5:1113–1124.PubMedCrossRef
13.
Zurück zum Zitat Radhofer-Welte S. Pharmacokinetics and metabolism of the proton-pump inhibitor pantoprazole in man. Drugs Today (Barc). 1999;35:765–772. Radhofer-Welte S. Pharmacokinetics and metabolism of the proton-pump inhibitor pantoprazole in man. Drugs Today (Barc). 1999;35:765–772.
14.
Zurück zum Zitat Nardino RJ, Vender RJ, Herbert PN. Overuse of acid-suppressive therapy in hospitalized patients. Am J Gastroenterol. 2000;95:3118–3122.PubMed Nardino RJ, Vender RJ, Herbert PN. Overuse of acid-suppressive therapy in hospitalized patients. Am J Gastroenterol. 2000;95:3118–3122.PubMed
15.
Zurück zum Zitat Smith DM, Cox MR, Brazening EJ, et al. An intervention on discharge polypharmacy. J Am Geriatr Soc. 1996;44:416–419.PubMed Smith DM, Cox MR, Brazening EJ, et al. An intervention on discharge polypharmacy. J Am Geriatr Soc. 1996;44:416–419.PubMed
16.
Zurück zum Zitat Laheij RJ, Sturkenboom MC, Hassing RJ, Dieleman J, Stricker BH, Jansen JB. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA. 2004;292:1955–1960.PubMedCrossRef Laheij RJ, Sturkenboom MC, Hassing RJ, Dieleman J, Stricker BH, Jansen JB. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA. 2004;292:1955–1960.PubMedCrossRef
17.
Zurück zum Zitat Sarkar M, Hennessy S, Yang YX. Proton-pump inhibitor use and the risk for community acquired pneumonia. Ann Intern Med. 2008;149:391–398.PubMed Sarkar M, Hennessy S, Yang YX. Proton-pump inhibitor use and the risk for community acquired pneumonia. Ann Intern Med. 2008;149:391–398.PubMed
18.
Zurück zum Zitat Rodríguez LA, Ruigómez A, Wallander MA, Johansson S. Acid-suppressive drugs and community-acquired pneumonia. Epidemiology. 2009;20:800–806.PubMedCrossRef Rodríguez LA, Ruigómez A, Wallander MA, Johansson S. Acid-suppressive drugs and community-acquired pneumonia. Epidemiology. 2009;20:800–806.PubMedCrossRef
19.
Zurück zum Zitat Rath T, Walzer LR, Meissl G. Preventive measures for stress ulcers in burn patients. Burns Incl Therm Inj. 1988;14:504–507.PubMedCrossRef Rath T, Walzer LR, Meissl G. Preventive measures for stress ulcers in burn patients. Burns Incl Therm Inj. 1988;14:504–507.PubMedCrossRef
20.
Zurück zum Zitat Xiao SC, Zhu SH, Xia ZF, et al. Prevention and treatment of gastrointestinal dysfunction following severe burns: a summary of recent 30-year clinical experience. World J Gastroenterol. 2008;14:3231–3235.PubMedCrossRef Xiao SC, Zhu SH, Xia ZF, et al. Prevention and treatment of gastrointestinal dysfunction following severe burns: a summary of recent 30-year clinical experience. World J Gastroenterol. 2008;14:3231–3235.PubMedCrossRef
21.
Zurück zum Zitat Ali T, Harty RF. Stress-induced ulcer bleeding in critically ill patients. Gastroenterol Clin North Am. 2009 Jun;38:245–265.PubMedCrossRef Ali T, Harty RF. Stress-induced ulcer bleeding in critically ill patients. Gastroenterol Clin North Am. 2009 Jun;38:245–265.PubMedCrossRef
22.
Zurück zum Zitat Popović N. Importance of prevention of acute mucosal lesions in patients in intensive care units. Acta Chir Iugosl. 2007;54:47–50.PubMedCrossRef Popović N. Importance of prevention of acute mucosal lesions in patients in intensive care units. Acta Chir Iugosl. 2007;54:47–50.PubMedCrossRef
23.
Zurück zum Zitat Bickler SW, Harrison MW, Campbell JR. Perforated peptic ulcer disease in children: association of corticosteroid therapy. J Pediatr Surg. 1993;28:785–787.PubMedCrossRef Bickler SW, Harrison MW, Campbell JR. Perforated peptic ulcer disease in children: association of corticosteroid therapy. J Pediatr Surg. 1993;28:785–787.PubMedCrossRef
24.
Zurück zum Zitat Luo JC, Shin VY, Liu ES, et al. Non-ulcerogenic dose of dexamethasone delays gastric ulcer healing in rats. J Pharmacol Exp Ther. 2003;307:692–698.PubMedCrossRef Luo JC, Shin VY, Liu ES, et al. Non-ulcerogenic dose of dexamethasone delays gastric ulcer healing in rats. J Pharmacol Exp Ther. 2003;307:692–698.PubMedCrossRef
25.
Zurück zum Zitat Filaretova LP, Podvigina TT, Bagaeva TR, Tanaka A, Takeuchi K. Mechanisms underlying the gastroprotective action of glucocorticoids released in response to ulcerogenic stress factors. Ann NY Acad Sci. 2004;1018:288–292.PubMedCrossRef Filaretova LP, Podvigina TT, Bagaeva TR, Tanaka A, Takeuchi K. Mechanisms underlying the gastroprotective action of glucocorticoids released in response to ulcerogenic stress factors. Ann NY Acad Sci. 2004;1018:288–292.PubMedCrossRef
26.
Zurück zum Zitat Filaretova LP, Bagaeva TR, Podvigina TT, Morozova OI. Deficiency of glucocorticoid production delays the healing of acute gastric mucosal erosion and chronic ulcers in rats. Ross Fiziol Zh Im I M Sechenova. 2003;89:1137–1146.PubMed Filaretova LP, Bagaeva TR, Podvigina TT, Morozova OI. Deficiency of glucocorticoid production delays the healing of acute gastric mucosal erosion and chronic ulcers in rats. Ross Fiziol Zh Im I M Sechenova. 2003;89:1137–1146.PubMed
27.
Zurück zum Zitat Conn HO, Poynard T. Corticosteroids and peptic ulcer: meta-analysis of adverse events during steroid therapy. J Intern Med. 1994;236:619–632.PubMedCrossRef Conn HO, Poynard T. Corticosteroids and peptic ulcer: meta-analysis of adverse events during steroid therapy. J Intern Med. 1994;236:619–632.PubMedCrossRef
28.
Zurück zum Zitat Heidelbaugh JJ, Inadomi JM. Magnitude and economic impact of inappropriate use of stress ulcer prophylaxis in non-ICU hospitalized patients. Am J Gastroenterol. 2006;101:2200–2205.PubMedCrossRef Heidelbaugh JJ, Inadomi JM. Magnitude and economic impact of inappropriate use of stress ulcer prophylaxis in non-ICU hospitalized patients. Am J Gastroenterol. 2006;101:2200–2205.PubMedCrossRef
29.
Zurück zum Zitat Hwang KO, Kolarov S, Cheng L, Griffith RA. Stress ulcer prophylaxis for non-critically ill patients on a teaching service. J Eval Clin Pract. 2007;13:716–721.PubMedCrossRef Hwang KO, Kolarov S, Cheng L, Griffith RA. Stress ulcer prophylaxis for non-critically ill patients on a teaching service. J Eval Clin Pract. 2007;13:716–721.PubMedCrossRef
30.
Zurück zum Zitat Liberman JD, Whelan CT. Brief report: reducing inappropriate usage of stress ulcer prophylaxis among internal medicine residents. A practice-based educational intervention. J Gen Intern Med. 2006;21:498–500.PubMedCrossRef Liberman JD, Whelan CT. Brief report: reducing inappropriate usage of stress ulcer prophylaxis among internal medicine residents. A practice-based educational intervention. J Gen Intern Med. 2006;21:498–500.PubMedCrossRef
31.
Zurück zum Zitat Pitimana-aree S, Forrest D, Brown G, Anis A, Wang XH, Dodek P. Implementation of a clinical practice guideline for stress ulcer prophylaxis increases appropriateness and decreases cost of care. Intensive Care Med. 1998;24:217–223.PubMedCrossRef Pitimana-aree S, Forrest D, Brown G, Anis A, Wang XH, Dodek P. Implementation of a clinical practice guideline for stress ulcer prophylaxis increases appropriateness and decreases cost of care. Intensive Care Med. 1998;24:217–223.PubMedCrossRef
Metadaten
Titel
Physicians’ Opinions of Stress Ulcer Prophylaxis: Survey Results from a Large Urban Medical Center
verfasst von
Charles P. Koczka
Laura B. Geraldino-Pardilla
Adam J. Goodman
Publikationsdatum
01.03.2013
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 3/2013
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-012-2423-x

Weitere Artikel der Ausgabe 3/2013

Digestive Diseases and Sciences 3/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.